AIMS/HYPOTHESES: We previously reported that lower n-3 fatty acid intake and levels in erythrocyte membranes were associated with increased risk of islet autoimmunity (IA) but not progression to type 1 diabetes in children at increased risk for diabetes. We hypothesise that specific n-3 fatty acids and genetic markers contribute synergistically to this increased risk of IA in the Diabetes Autoimmunity Study in the Young (DAISY). METHODS: DAISY is following 2,547 children at increased risk for type 1 diabetes for the development of IA, defined as being positive for glutamic acid decarboxylase (GAD)65, IA-2 or insulin autoantibodies on two consecutive visits. Using a case-cohort design, erythrocyte membrane fatty acids and dietary intake were measured prospectively in 58 IA-positive children and 299 IA-negative children. RESULTS: Lower membrane levels of the n-3 fatty acid, docosapentaenoic acid (DPA), were predictive of IA (HR 0.23; 95% CI 0.09, 0.55), while α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not, adjusting for HLA and diabetes family history. We examined whether the effect of dietary intake of the n-3 fatty acid ALA on IA risk was modified by fatty acid elongation and desaturation genes. Adjusting for HLA, diabetes family history, ethnicity, energy intake and questionnaire type, ALA intake was significantly more protective for IA in the presence of an increasing number of minor alleles at FADS1 rs174556 (pinteraction = 0.017), at FADS2 rs174570 (pinteraction = 0.016) and at FADS2 rs174583 (pinteraction = 0.045). CONCLUSIONS/ INTERPRETATION: The putative protective effect of n-3 fatty acids on IA may result from a complex interaction between intake and genetically controlled fatty acid desaturation.
AIMS/HYPOTHESES: We previously reported that lower n-3 fatty acid intake and levels in erythrocyte membranes were associated with increased risk of islet autoimmunity (IA) but not progression to type 1 diabetes in children at increased risk for diabetes. We hypothesise that specific n-3 fatty acids and genetic markers contribute synergistically to this increased risk of IA in the Diabetes Autoimmunity Study in the Young (DAISY). METHODS: DAISY is following 2,547 children at increased risk for type 1 diabetes for the development of IA, defined as being positive for glutamic acid decarboxylase (GAD)65, IA-2 or insulin autoantibodies on two consecutive visits. Using a case-cohort design, erythrocyte membrane fatty acids and dietary intake were measured prospectively in 58 IA-positive children and 299 IA-negative children. RESULTS: Lower membrane levels of the n-3 fatty acid, docosapentaenoic acid (DPA), were predictive of IA (HR 0.23; 95% CI 0.09, 0.55), while α-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were not, adjusting for HLA and diabetes family history. We examined whether the effect of dietary intake of the n-3 fatty acidALA on IA risk was modified by fatty acid elongation and desaturation genes. Adjusting for HLA, diabetes family history, ethnicity, energy intake and questionnaire type, ALA intake was significantly more protective for IA in the presence of an increasing number of minor alleles at FADS1rs174556 (pinteraction = 0.017), at FADS2rs174570 (pinteraction = 0.016) and at FADS2rs174583 (pinteraction = 0.045). CONCLUSIONS/ INTERPRETATION: The putative protective effect of n-3 fatty acids on IA may result from a complex interaction between intake and genetically controlled fatty acid desaturation.
Authors: Jyrki K Virtanen; Asenath N Nyantika; Jussi Kauhanen; Sari Voutilainen; Tomi-Pekka Tuomainen Journal: Hypertens Res Date: 2012-06-07 Impact factor: 3.872
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Peter Rzehak; Joachim Heinrich; Norman Klopp; Linda Schaeffer; Sebastian Hoff; Günther Wolfram; Thomas Illig; Jakob Linseisen Journal: Br J Nutr Date: 2008-05-15 Impact factor: 3.718
Authors: S Hellstrand; E Sonestedt; U Ericson; B Gullberg; E Wirfält; B Hedblad; M Orho-Melander Journal: J Lipid Res Date: 2012-03-26 Impact factor: 5.922
Authors: Ryan W Gan; Kendra A Young; Gary O Zerbe; M Kristen Demoruelle; Michael H Weisman; Jane H Buckner; Peter K Gregersen; Ted R Mikuls; James R O'Dell; Richard M Keating; Michael J Clare-Salzler; Kevin D Deane; V Michael Holers; Jill M Norris Journal: Rheumatology (Oxford) Date: 2015-09-13 Impact factor: 7.580
Authors: Sari Niinistö; Hanna-Mari Takkinen; Iris Erlund; Suvi Ahonen; Jorma Toppari; Jorma Ilonen; Riitta Veijola; Mikael Knip; Outi Vaarala; Suvi M Virtanen Journal: Diabetologia Date: 2017-05-04 Impact factor: 10.122
Authors: Suzanne J Meldrum; Yuchun Li; Guicheng Zhang; Alexandra E M Heaton; Nina D'Vaz; Judith Manz; Eva Reischl; Berthold V Koletzko; Susan L Prescott; Karen Simmer Journal: Eur J Nutr Date: 2017-09-19 Impact factor: 5.614
Authors: Wendy K Chung; Karel Erion; Jose C Florez; Andrew T Hattersley; Marie-France Hivert; Christine G Lee; Mark I McCarthy; John J Nolan; Jill M Norris; Ewan R Pearson; Louis Philipson; Allison T McElvaine; William T Cefalu; Stephen S Rich; Paul W Franks Journal: Diabetologia Date: 2020-09 Impact factor: 10.122
Authors: Teresa Buckner; Lauren A Vanderlinden; Brian C DeFelice; Patrick M Carry; Katerina Kechris; Fran Dong; Oliver Fiehn; Brigitte I Frohnert; Michael Clare-Salzler; Marian Rewers; Jill M Norris Journal: Diabetologia Date: 2021-04-24 Impact factor: 10.460
Authors: Brittni N Frederiksen; Miranda Kroehl; Anna Barón; Molly M Lamb; Tessa L Crume; Marci K Sontag; Marian Rewers; Jill M Norris Journal: Biomed Res Int Date: 2015-03-25 Impact factor: 3.411